India's pharmaceutical exports increased nearly 5 percent, reaching USD 16.13 billion in the first half of the fiscal year. Growth was driv...

Cheaper nivolumab biosimilars are expanding access to cancer immunotherapy in India, with one Mumbai oncologist reporting a more than 50% r...

For millions of cancer patients, the cost of treatment can be as frightening as the diagnosis. From steep markups to patented drugs that re...

The Kerala High Court has stressed the importance of making cancer medicines like ribociclib more affordable for patients. The Government o...

Zydus Lifesciences has received acceptance for its application regarding the biosimilar of Keytruda, which is a major cancer drug. The USFD...

An expert group is finalizing the list of cancer medicines for a new trade margin cap. The government plans to implement a 30% cap to reduc...

The Supreme Court has asked the government to address high markups on medicines and medical devices. The court questioned the decision to l...

Hospital stocks rose up to 5% after the government capped trade margins on non-scheduled anti-cancer drugs at 30%, potentially reducing med...

The government is aiming to cap trade margins on anti-cancer medications at 30%. An expert committee has been tasked with compiling a repor...

The Supreme Court has ordered the government to establish a committee to investigate unethical pharmaceutical marketing. The committee is t...

Karnataka conducted inspections revealing significant price disparities between hospital procurement and patient billing for cancer drugs a...

The Kerala High Court ruled that government intervention is permissible for prohibitively priced patented medicines. The court directed the...

Novartis and Eli Lilly have opposed a Kerala High Court petition seeking government intervention to make two breast cancer drugs cheaper, d...

Bharat Biotech is “back in action” after a two-year post-Covid reset, founder Krishna Ella says, with the company expanding beyond vaccines...

Dr Reddy's Laboratories has taken a significant step in cancer care with the introduction of NIVORZ, a biosimilar of nivolumab. Designed to...

Biocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis re...

Cipla said its US unit has entered an exclusive partnership with China’s Qilu Pharmaceutical to license QL2107, a biosimilar of Merck’s can...